| 产品描述: | TAK1/MAP4K2 inhibitor 1 is a potent dual TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2) inhibitor, with IC50s of 41.1 nM and 18.2 nM, respectively. |
| 靶点: |
TAK1:41.1 nM (IC50);MAP4K2:18.2 nM (IC50) |
| 体内研究: |
TAK1/MAP4K2 inhibitor 1 has moderate terminal elimination half-life (t1/2=2.94 h for mice (1 mg/kg, iv)) |
| 参考文献: |
1. Tan L, et al. Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2). J Med Chem. 2015 Jan 8;58(1):183-96. |
| 溶解性: |
soluble in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.81 ml |
9.048 ml |
18.097 ml |
| 5 mM |
0.362 ml |
1.81 ml |
3.619 ml |
| 10 mM |
0.181 ml |
0.905 ml |
1.81 ml |
| 50 mM |
0.036 ml |
0.181 ml |
0.362 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |